checkAd
    Startseite > Aktien > Sight Sciences > Nachrichten
    Sight Sciences
    Aktie
    ISIN: US82657M1053 WKN: A3CU4L SYM: SGHT Land USA
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    6,8600
     
    USD
    +2,54 %
    +0,1700 USD
    Letzter Kurs 02:00:00 Nasdaq
    Geldkurs
    12.06.24
    6,8600
     
    USD
    200 STK
    Briefkurs
    12.06.24
    6,8800
     
    USD
    100 STK

    Sight Sciences Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Sight Sciences Announces the Release of its First Sustainability Report
    10.06.24 · globenewswire · Sight Sciences
    Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis
    28.05.24 · globenewswire · Sight Sciences
    Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI Across Mild, Moderate, and Advanced Glaucoma
    28.05.24 · globenewswire · Sight Sciences
    Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
    07.05.24 · globenewswire · Sight Sciences
    Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance
    02.05.24 · globenewswire · Sight Sciences
    Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery
    29.04.24 · globenewswire · Sight Sciences
    Sight Sciences to Report First Quarter Financial Results on May 2, 2024
    18.04.24 · globenewswire · Sight Sciences
    Sight Sciences gibt die Veröffentlichung einer groß angelegten, praxisnahen MIGS-Studie als Nachweis für die Wirksamkeit des umfassenden Verfahrens zur Wiederherstellung des Kammerwasserabflusses mit der OMNI Surgical System-Technologie sowohl bei der Sen
    12.04.24 · globenewswire · Sight Sciences
    Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Y
    10.04.24 · globenewswire · Sight Sciences
    Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
    02.04.24 · globenewswire · Sight Sciences
    Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference
    26.03.24 · globenewswire · Sight Sciences
    Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance
    07.03.24 · globenewswire · Sight Sciences